Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, Roisin E. O'Cearbhaill

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that there was an error in one of the author names. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)225
Number of pages1
JournalGynecologic oncology
Volume143
Issue number1
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))'. Together they form a unique fingerprint.

Cite this